Bioliberty announced today that it launched its first product, the Lifehub Clinic, as a hub for a portfolio of soft-robotic wearables. The company describes its offering as an affordable, portable modular solution. It aims to assist therapists with delivering high-intensity, engaging therapy in clinical settings. The system will serve as a hub for a portfolio […]
MassDevice Neurological Hub

MassDevice's Neurological Hub is your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ A Medtronic engineer shares lessons from the adaptive deep brain stimulation project
+ Analysts see $400B BCI opportunity
+ 7 neurotech companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ 7 brain-computer interface companies you need to know
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech
Medtronic and Boston Scientific both face patient lawsuits related to spinal cord stimulation (SCS) technologies. The Minnesota Star Tribune reported last week that, in a lawsuit filed in Minnesota, patients alleged that Medtronic circumvented necessary regulatory approvals as it continued to update its SCS systems over several decades. Similar complaints target Boston Scientific and its […]
Imperative Care expands Zoom Stroke System with new dual-catheter launch
Imperative Care announced today that it expanded its Zoom Stroke System with the launch of its Zoom DuoPort technology. Zoom DuoPort allows physicians to continue using the novel continuous dual-aspiration technique (CDAT) on two Zoom aspiration catheters simultaneously from a single vacuum source. CDAT enables enhanced aspiration control and immediate clot feedback from within the […]
LivaNova submits nerve stim for sleep apnea to FDA, raises 2025 guidance
LivaNova today announced 12-month data from its OSPREY study supporting an FDA submission of the aura6000 system. The London-based medtech company recently completed its submission based on meeting OSPREY’s primary safety and efficacy endpoints. It submitted six-month data and provided 12-month interim results with plans to share the full 12-month dataset during the review. aura6000 […]
Route 92 Medical settles patent spat with Q’Apel
Route 92 Medical announced today that it settled the patent litigation filed against Q’Apel Medical over delivery catheter intellectual property. San Mateo, California–based Route 92 develops a suite of reperfusion and access systems leveraging the patented Tenzing delivery catheter. The products aim to improve the efficiency of endovascular thrombectomy procedures. The company designed its technology […]
InBrain Neuroelectronics picks up $4.5M grant to support BCI development
InBrain Neuroelectronics announced today that it received a $4.5 million (€4 million) grant from Spain’s PERTE Chip Program. The Spanish Ministry of Industry and Tourism awarded the grant through its PERTE Chip initiative for the Barcelona-based company. Spain’s PERTE Chip initiative aims to strengthen design and production capabilities for the country’s microelectronics and semiconductor industry. […]
Nuro hits communication milestone with non-surgical neurotech
Nuro recently announced a new clinical milestone with its third-generation neural operating system, NUOS 3. The company reports that NUOS 3 can enable patients who have been declared clinically dead — at times for over 30 minutes — and later resuscitated to regain the ability to communicate. Despite complete entrapment and often suffering severe diffuse […]
ElectroCore completes acquisition of NeuroMetrix
ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix (Nasdaq:NURO). In December 2024, Rockaway, New Jersey-based ElectroCore struck a deal to acquire NeuroMetrix and its neuromodulation platform. Quell, a solution for treating fibromyalgia and lower-extremity chronic pain, adds to ElectroCore’s portfolio of non-invasive bioelectronic therapies. ElectroCore expects the wearable, app- and […]
Neuralink wins FDA breakthrough nod for treating speech impairment
Neuralink said today on social media that it received FDA breakthrough device designation for treating individuals with severe speech impairment. This breakthrough nod extends to a number of neurological conditions, according to a LinkedIn post made by the Elon Musk-backed brain-computer interface (BCI) maker. “We’ve received Breakthrough Device Designation from the FDA to help restore […]
Precision Neuroscience strengthens leadership following FDA clearance for BCI tech
Precision Neuroscience announced today that it appointed two significant leadership figures to support its brain-computer interface (BCI) tech. The appointments come on the heels of the recent FDA 510(k) clearance for the Layer 7 cortical interface for BCI technology. The Layer 7 thin-film BCI features 1,024 electrodes embedded in a flexible film that conforms to the brain […]
Spark Biomedical closes $15M Series A for wearable neurostim
Spark Biomedical announced today that it closed a $15 million Series A round to support its bioelectronic neurostimulation technologies. Wave Ventures led the financing round, which also received support from Pathway to Cures. The company plans to use funds to accelerate the development of its bioelectronic treatments. Funding supports the core areas of its business: […]